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Abstract:  28 
Purpose: An observational study using routinely-collected healthcare data to describe the 29 
extent to which children and young people (CYP) with cerebral palsy (CP) can be identified and 30 
estimate the prevalence of CP. 31 
 32 
Patients and methods: Routinely-collected anonymized data, for CYP (aged 0 to 25 years old 33 
between 1st January 2004 and 31st December 2014) were analyzed in two linked datasets, 34 
from England and Wales respectively. Datasets included National Health Service; General 35 
Practitioner (GP), inpatients, outpatients, and national mortality records. CP was identified using 36 
ICD-10 codes G80.0-G83.3 and equivalent Read v2 codes. Ascertainment rates of CP were 37 
identified for each data source and compared between countries. Frequency and consistency of 38 
coding were investigated, and prevalence of CP estimated. 39 
 40 
Results: 7,113 and 5,218 CYP with a CP were identified in the English and the Welsh datasets 41 
respectively. Whilst the majority of CYP with a CP would be expected to attend their GP, 65.3% 42 
(4,646/7,113) of English and 65.1% (3,396/5,218) of Welsh cases were ascertained from GP 43 
datasets. Further cases were identified solely in inpatient datasets (2,410 in England, 1,813 in 44 
Wales). Few cases were coded for CP within outpatient datasets.  Four character codes that 45 
specified CP type were rarely used; one in five healthcare records were coded both with G80 46 
codes (explicitly CP) and with G81-83 codes (other paralytic syndromes) or equivalent Read 47 
codes. Estimated period prevalence of CYP with CP was 2.5-3.4 per 1000 in England and 2.4-48 
3.2 per 1000 in Wales. 49 
 50 
Conclusion: In England and Wales, coding of CP in routine data is infrequent, inconsistent, 51 
non-specific, and difficult to isolate from conditions with similar physical signs. Yet the 52 
prevalence estimates of CP were similar to those reported elsewhere. To optimise case 53 
recognition we recommend improved coding quality and the use of both primary and secondary 54 
care datasets as a minimum. 55 
 56 
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Introduction 58 
Routinely-collected healthcare data within the National Health Service (NHS) offers the 59 
opportunity to estimate the prevalence of cerebral palsy (CP) and explore the frequency and 60 
consistency of CP coding for this group of children and young people (CYP).  61 
 62 
The term CP encompasses a group of permanent but non-progressive disorders of movement 63 
and posture development caused by neurological disturbances in early life.1 These are the most 64 
commonly occurring childhood physical disabilities.2 Presenting in early infancy, most cases are 65 
diagnosed by the age of 2 years  CP is a lifelong condition that is associated with multiple co-66 
existing health problems including disorders of sensation, cognition, behavior, epilepsy and 67 
musculoskeletal problems.1 Patients often require a multi-disciplinary range of both primary 68 
(General Practitioner; GP) and secondary (hospital) care.   69 
 70 
Prevalence estimates of CP vary between studies, generally falling between 2 and 3 per 1000 in 71 
developed countries,3 however prevalence of the different CP subtypes is unclear.4 In England 72 
and Wales, it has been estimated that 22,100 children between 3-15 years of age will be living 73 
with CP by 2020.5 Prevalence of CP has been linked to sex,6.7 ethnicity8 and socioeconomic 74 
status,9however these factors have not been explored at a national level within England and 75 
Wales. Previous estimates of CP prevalence in the UK,10-12 calculated from sources such as 76 
local registers or surveys, are regionally restricted, and data from these studies are now more 77 
than 20 years old.  Despite the complex and ongoing healthcare needs of CYP with CP, we lack 78 
a comprehensive understanding of both the epidemiology and the burden of CP on healthcare 79 
services. 80 
 81 
The use of routinely-collected administrative data has been widely promoted13,14 over the past 82 
decade by funders and policy makers on the basis that it can provide a low-cost source of pre-83 
existing, large population data, spanning long periods of time. However, as these data are 84 
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primarily collected for reimbursement and commissioning purposes, they are potentially 85 
problematic from a research perspective as the completeness, consistency and accuracy of 86 
variables recorded that aren’t pertinent to the primary purpose of the dataset are less likely to be 87 
rigorously checked by the data provider.15,16 In the UK coding of some chronic conditions 88 
(including asthma and COPD) is incentivized by the Quality and Outcomes Framework (QOF);17 89 
however CP is not included on this list and the extent to which the condition is coded may be 90 
compromised by the fact that the primary reason for each attendance is due to an associated or 91 
unrelated illness and the underlying chronic condition may not be recorded.  92 
 93 
Studies of chronic and complex conditions such as congenital anomalies,18 asthma,19 and 94 
COPD20 have successfully employed UK administrative data to investigate healthcare service 95 
use by linking routinely-collected data from primary and secondary care settings. A growing 96 
body of studies in Australia,21-23 have linked a range of administrative health records (including 97 
register data and hospital admissions) to explore CP healthcare questions and studies from the 98 
USA24,25 have used administrative records to determine CP healthcare costs. These studies do 99 
not take account of Primary Care data. Whilst pediatricians in the secondary healthcare sector 100 
are most likely to make the initial diagnosis of a CP, most children will attend their GP practice 101 
at some time and their underlying medical condition should be coded in routinely-collected 102 
primary healthcare datasets. Thus, UK studies that link primary and secondary healthcare data 103 
have the potential to optimize case ascertainment.  104 
 105 
In this study, two sets of linked primary, secondary, and mortality administrative data, one from 106 
England and one from Wales, were used to determine how CP cases can be ascertained, 107 
estimate the prevalence of the condition, and to understand the potential strengths and 108 
limitations of using routine data to evaluate healthcare utilization for CYP with CP. 109 
  110 
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Material and methods 111 
Data  112 
Routinely-collected anonymized data, for patients aged 0 to 25 years old between 1st January 113 
2004 and 31st December 2014, were analyzed in two separately linked datasets for England 114 
and for Wales. Each linked dataset included healthcare records (GP, inpatients and outpatients) 115 
from the NHS, and mortality records (death register).  116 
The English dataset comprised GP records held in the Clinical Practice Research Datalink 117 
(CPRD), linked to Hospital Episode Statistics (HES) inpatient data from Admitted Patient Care 118 
(APC), outpatient data from Outpatients Dataset (OPD), and mortality data (including causes of 119 
death) from the Office for National Statistics (ONS). The CPRD dataset is a primary care 120 
research database of de-identified patient data from a network of GP practices across the UK. 121 
Primary care data are linked to a range of other health related data to provide a longitudinal, 122 
representative UK population healthcare dataset. The linked dataset included more than 10 123 
million registered patients and represents an estimated 5.34% of the population of England.26,27  124 
The Welsh dataset was hosted by Secure Anonymized Information Linkage Databank (SAIL) 125 
The SAIL databank anonymously record-links routinely-collected data held in health and social 126 
care datasets at the Centre for Improvement in Population Health through E-records Research, 127 
Swansea University, United Kingdom which was part of the Farr Institute.28  For each dataset 128 
within the SAIL databank, an individual is assigned an Anonymized Linking Field, based on their 129 
names, address, or National Health Service number, which is used to link back to their medical 130 
records hosted in the SAIL databank.29 131 
 132 
The Welsh dataset included 100% of Welsh hospital records and records from approximately 133 
70% of GP practices. This dataset comprised inpatient data from Patient Electronic Dataset 134 
Wales (PEDW), data from Outpatients Dataset Wales (OPDW), and ONS (known as the Annual 135 
District Death Extract or ADDE in SAIL) linked to GP records from the Wales General Practice 136 
Dataset (WLGP). 137 
 138 
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Datasets were linked primarily by NHS number (although where this was not possible, a 139 
combination of alternative patient identifiable fields were used).30 Linkage was conducted by 140 
NHS Digital and CPRD in England, and SAIL in Wales.31  141 
 142 
The study was approved as part of a wider project30 under Section 3 of the Health and Social 143 
Care Act. Data were requested from CPRD, and SAIL and access to the data was granted 144 
following approval of our study by the Independent Scientific Advisory Committee (ISAC) for 145 
CPRD data and the Information Governance Review Panel (IGRP) for SAIL data. 146 
Identifying cases of CP 147 
Each source of healthcare data for these patients was searched for CP codes from 1st January 148 
1979 and 31st December 2014 to identify all potential cases of CP that were aged 0 to 25 years 149 
at any point during the study period of 1st January 2004 to 31st December 2014. Records were 150 
searched from the 1st January 1979 as a young person born on the 1st January 1979 would turn 151 
25 on the 1st January 2004 and any children born after that would be younger and therefore 152 
included within the study period. 153 
Cases falling under the definition “Cerebral palsy and other paralytic syndromes” as stated in 154 
the International Statistical Classification of Diseases and Related Health Problems 10th 155 
Revision (ICD-10) were included as cases of possible CP; specifically, those coded in hospital 156 
and mortality data using ICD-10 codes G80.0-83.3. Whilst ICD-10 G80.0-G80.9 codes are 157 
specific to CP, G81.0-83.3 were also included to account for cases that may have been coded 158 
by the extent of limb paralysis experienced rather than the disease specific codes.  159 
 160 
An equivalent list of Read codes, v2 5-character for Welsh GP data and v2 7-character for 161 
English GP data, were identified (see Appendix A). Read codes were derived from a previously 162 
published list of Read codes diagnostic for CP,32 and supplemented by subsequently introduced 163 
relevant Read codes, to provide 44 possible Read codes for CP.  This list was converted to 164 
medcodes that are used in CPRD. The list of Read codes for GP data in the Welsh dataset was 165 
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created by matching Read v2 5-character codes to the ICD 10 codes of interest (G80.0-G83.3), 166 
based upon individual code definitions. This is due to the Welsh dataset using the 5-character 167 
Read codes rather than the 7-character code used in CPRD. Combining the CPRD and SAIL 168 
code lists resulted in a list of 61 possible Read codes used to identify cases of CP in GP data.  169 
 170 
CP cases were flagged in the data if the patient had been coded as above at any time in their 171 
patient history records before the age of 25 years. The rest of the population who were aged 0 172 
to 25 years between 2004 and 2014 and did not have a CP diagnosis code anywhere in their 173 
healthcare or mortality data were flagged as “non-CP cases”. 174 
 175 
Data cleaning and preparation 176 
In both English and Welsh datasets, individuals were assigned an anonymized patient identifier. 177 
Records were excluded within CPRD and SAIL if there were multiple hospital admissions on the 178 
same date for the same individual, if the event fell outside age range or time period of interest, 179 
or the probabilistic matching was below the adequate threshold. The probabilistic matching was 180 
deemed acceptable if the patient identifier were unique to a patient and there was an exact 181 
match on NHS number, date of birth, and sex with or without postcode. The overall dataset 182 
included 2,122,909 CYP for England and 1,636,252 for Wales. Figures reported here differ 183 
marginally to those previously reported30 as more rigorous data cleaning was subsequently 184 
undertaken for this study. 185 
 186 
Data Analysis 187 
Case ascertainment 188 
The number and proportion of the total cases of possible CP that were identified from each 189 
source of healthcare data (GP, inpatients, outpatients, and mortality) were compared both within 190 
each linked dataset and between England and Wales. 191 
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 192 
Coding consistency 193 
The proportion of four-character ICD-10 codes used in hospital and mortality datasets for the 194 
study population were compared for patients in England and Wales. To explore the consistency 195 
of coding, the different combinations of 3-character ICD codes and equivalent Read codes 196 
applied to the same individual in hospital and GP data respectively were recorded. Three-197 
character ICD-10 code group G80 (G80.0-G80.9), G81 (G81.0-G81.9), G82 (G82.0-G82.5) and 198 
G83 (G83.0-G83.3) and equivalent Read codes were applied in this analysis (Appendix A). The 199 
proportions of patients with CP that had only one 3-character CP code recorded were compared 200 
between data sources and countries and these cases were broken down by age group to 201 
identify consistency of coding throughout their records. The proportion of cases that were coded 202 
as ‘cerebral palsy’ (ie G80.0-G80.9 or Read v2 equivalents) were compared to the other code 203 
groups (hemiplegia (G81.0-G81.9), paraplegia and tetraplegia (G82.0-G82.5), and other 204 
paralytic syndromes (G83.0-G83.3)). 205 
 206 
Prevalence of CP 207 
The total number of possible CP cases identified within each linked dataset were used to 208 
calculate crude period prevalence rates per 1000 population at risk within each dataset for each 209 
nation between 1st January 2004 and 31st December 2014. The denominator used for the 210 
English dataset consisted of CPRD’s anonymized list of patients who had linkable GP and 211 
secondary care data (if any) of an acceptable standard for research purposes, who were aged 0 212 
to 25 years at any point during the study period (n=2,122,909 CYP). For the Welsh dataset, the 213 
denominator included all CYP within SAIL [anonymized] aged 0 to 25 years and resident in 214 
Wales (and satisfying SAIL’s quality assurance checks) at any point during the study period 215 
(n=1,636,252). To investigate demographic characteristics of possible CP cases in each nation, 216 
prevalence estimates were broken down by gender and Index of Multiple Deprivation (IMD)33 (or 217 
WIMD in Wales)34 quintiles, and 95% confidence intervals were calculated for each. Deprived 218 
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areas were defined as those within the 4th or 5th quintiles. Estimated prevalence rates were also 219 
calculated after exclusion of cases only ever coded as other paralytic conditions (ie ICD-10 220 
G81.0-G83.3 codes and their READ v2 code equivalents). 221 
 222 
Results 223 
Ascertainment 224 
Applying the ICD-10 and Read v2 codes for CP and other paralytic conditions, a total of 7,113 225 
patients in the English dataset, and 5,218 patients in the Welsh dataset were identified (Fig 1 226 
and 2). For England 65.3% (4,646/7,113) of cases of possible CP were identified in the GP 227 
dataset, 67.2% (3,121/4,646) of which were also identified in inpatient data. However, a further 228 
2,410 cases were identified within inpatient data that were not coded in the GP dataset. A 229 
similar pattern was seen in the Welsh dataset (GP identified 65.1% (3,396/5,218), 61.0% 230 
(2,073) of whom were within the inpatient dataset and a further 1,813 were identified in inpatient 231 
data but not in the GP data). Very few cases were identified from outpatient datasets in either 232 
country. Most cases within the mortality dataset were also identified within the inpatient dataset 233 
(England 93.7% (148/158); Wales 97.5% (237/243)). 234 
 235 
 236 
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 237 
Figure 1. Venn diagram showing the sources of identification of 7,113 CP cases within the 238 
English dataset (1979-2014). 239 
 240 
 241 
 242 
Figure 2. Venn diagram showing the sources of identification of 5,218 CP cases within the 243 
Welsh dataset (1979-2014). 244 
 245 
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Despite multiple healthcare attendances, approximately 30% of CYP were coded only once for 246 
possible CP (29.5% 2,095/7,113 in England and 32.3% 1,685/5,218 in Wales).  Of these cases, 247 
15.8% (England) and 13.7% (Wales) were less than one year old when CP was coded. 248 
 249 
Coding practices 250 
In both hospital and mortality data, the most commonly recorded code was G80.9 “Cerebral 251 
Palsy, unspecified” (Table 1). Hence, in a large proportion of cases the type of CP was not 252 
coded.  253 
 254 
ICD-10 
code 
ICD description England Wales 
Inpatients 
(%) 
Outpatients 
(%) 
Mortality 
(%) 
Inpatients 
(%) 
Outpatients 
(%) 
Mortality 
(%) 
G80.0 Spastic quadriplegic cerebral 
palsy 
7.5 4.2 0.7 8.1 16.7 2.2 
G80.1 Spastic diplegic cerebral palsy 7.4 3.6 0.7 8.6 0.0 0.7 
G80.2 Spastic hemiplegic cerebral palsy 3.1 0.9 0.0 4.3 0.0 0.0 
G80.3 Dyskinetic cerebral palsy 3.1 0.7 1.7 2.7 0.0 0.7 
G80.4 Ataxic cerebral palsy 0.3 0.4 0.0 0.5 0.0 0.0 
G80.8 Other cerebral palsy 10.2 13.2 1.7 10.3 6.7 2.9 
G80.9 Cerebral palsy, unspecified 42.3 69.1 84.3 44.3 53.3 84.7 
G81.0 Flaccid hemiplegia 0.1 0.1 0.0 0.1 0.0 0.0 
G81.1 Spastic hemiplegia 0.2 0.3 0.0 0.3 0.0 0.0 
G81.9 Hemiplegia, unspecified 12.0 6.6 0.0 10.1 20.0 0.0 
G82.0 Flaccid paraplegia 0.2 0.0 0.0 0.2 0.0 0.4 
G82.1 Spastic paraplegia 0.9 0.1 0.0 0.5 0.0 0.0 
G82.2 Paraplegia, unspecified 3.2 0.8 0.7 3.1 0.0 0.0 
G82.3 Flaccid tetraplegia 0.1 0.0 0.0 0.0 0.0 0.0 
G82.4 Spastic tetraplegia 5.1 0.0 7.6 5.1 3.3 4.0 
G82.5 Tetraplegia, unspecified 3.5 0.0 2.7 1.5 0.0 4.4 
G83.0 Diplegia of upper limbs 0.1 0.0 0.0 0.1 0.0 0.0 
G83.1 Monoplegia of lower limb 0.3 0.0 0.0 0.1 0.0 0.0 
G83.2 Monoplegia of upper limb 0.2 0.0 0.0 0.2 0.0 0.0 
G83.3 Monoplegia, unspecified 0.1 0.0 0.0 0.0 0.0 0.0 
 Total number of codes 45391 * * 24317 * * 
 255 
Table 1. Percentage of each four-character code used for the total ICD-10 G80.0-83.3 codes 256 
applied to NHS contacts in inpatients, outpatients and mortality data for England and Wales 257 
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(2004-2014). * Due to disclosure of small numbers that have the potential to identify individual 258 
cases we are unable to give the number of codes observed for Outpatient and Mortality data for 259 
both England and Wales. 260 
 261 
Overall, 74.5% (5,284/7,113) of cases in England and 75.0% (3,911/5,218) of cases in Wales 262 
were specifically identified as “Cerebral palsy” (G80.0-G80.9 codes or an equivalent Read v2 263 
code) at least once (Table 2) during their multiple attendances. Several of these cases were 264 
also coded as either “Hemiplegia”, “Paraplegia and Tetraplegia”, “Other paralytic syndromes” 265 
(G81, 82 or 83), or a combination these. Patterns of multiple coding were similar between the 266 
datasets for the two countries and between primary and secondary care. Approximately one in 267 
four cases were only ever coded as ‘other paralytic syndrome’ G81-83. 268 
Codes given* 
Inpatients and 
Outpatients 
GP 
England N = 5,614 N = 4,646 
Cerebral palsy (G80) 4184 (74.5%) 3524 (75.9%) 
 Cerebral palsy (G80) only 3119 (55.6%) 2818 (60.7%) 
 Cerebral palsy (G80) & Hemiplegia (G81) 500 (8.9%) 407 (8.8%) 
 Cerebral palsy (G80) & Paraplegia and Tetraplegia 
(G82) 
497 (8.9%) 257 (5.5%) 
 Cerebral palsy (G80) & Other paralytic syndromes 
(G83) 
27 (0.5%) 23 (0.5%) 
 Cerebral palsy (G80) and multiple other codes 
(G81-83) 
41 (1.0%) 19 (0.5%) 
Other paralytic syndromes (G81-83) 1430 (25.5%) 1122 (24.1%) 
Wales N = 3,892 N = 3,396 
Cerebral palsy (G80) 2974 (76.4%) 2520 (74.2%) 
 Cerebral palsy (G80) only 2361 (60.7%) 1915 (56.5%) 
 Cerebral palsy (G80) & Hemiplegia (G81) 289 (7.4%) 400 (11.8%) 
 Cerebral palsy (G80) & Paraplegia and Tetraplegia 
(G82) 
281 (7.2%) 168 (5.0%) 
 Cerebral palsy (G80) & Other paralytic syndromes 
(G83) 
20 (0.5%) 15 (0.4%) 
 Cerebral palsy (G80) and multiple other codes 
(G81-83) 
23 (0.8%) 22 (0.9%) 
Other paralytic syndromes (G81-83) 918 (23.6%) 876 (25.8%) 
 269 
Table 2. Frequency and percentage usage of 3-character ICD-10 codes (or equivalent Read v2 270 
code) per individual CYP with CP in primary and secondary care data. *See appendix A for 271 
equivalent Read codes. 272 
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Prevalence 273 
The crude period prevalence for 2004-2014 of CYP (less than 25 years of age) with CP or other 274 
paralytic syndromes was 3.4 per 1000 in England (7,113/2,122,909) and 3.2 per 1000 275 
(5,218/1,636,252) in Wales. Prevalence was higher in males than females and in the most 276 
deprived areas compared to least deprived in both England and Wales (Table 3).  277 
 278 
Demographic Prevalence of CP or other paralytic conditions (G80-G83) 
England Wales  
Gender N  Rate (95% CI) N Rate (95% CI) 
Male  1,039,850 3.8 (3.7-4.0) 820,532 3.6 (3.5-3.8) 
Female  1,083,042 2.9 (2.8-3.0) 815,713 2.7 (2.6-2.9) 
IMD   
1 – Least Deprived 434,229 3.0 (2.9-3.2) 287,927 3.1 (2.9-3.3) 
2 425,447 3.3 (3.1-3.4) 266,765 3.2 (3.0-3.4) 
3 404,969 3.3 (3.1-3.5) 273,750 3.4 (3.2-3.6) 
4 447,706 3.5 (3.3-3.6) 290,747 3.4 (3.2-3.6) 
5 – Most Deprived 408,157 3.8 (3.6-3.9) 324,153 3.6 (3.4-3.8) 
 279 
Table 3: Cerebral Palsy/ other paralytic syndromes (G80.0-G83.3) period prevalence per 1000 280 
population at risk for 2004-2014 by gender and social deprivation (quintiles of English indices of 281 
deprivation 2010 and Welsh Index of Multiple Deprivation 2011) within England and Wales. 282 
Confidence intervals (CIs) in brackets. NB sex and IMD denominators do not equal the total 283 
number of cases in the two datasets due to missing data. 284 
 285 
When narrowing case identification to those coded at least once explicitly as CP (ie G80.0-286 
G80.9 and equivalent Read v2 codes), 5,284 English cases, and 3,911 Welsh cases of CP were 287 
identified and period prevalence of CYP with a CP reduced to 2.5 per 1000 (95% CI: 2.4 – 2.6) 288 
for England and 2.4 per 1000 (95% CI: 2.3 – 2.5) for Wales.  289 
Discussion 290 
To the best of our knowledge, this is the first study to describe the ascertainment of CYP with 291 
CP from data-linkage of routinely-collected primary, secondary care, and mortality data in 292 
England and in Wales. We found that the coding of CP in these records was infrequent, 293 
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inconsistent, and non-specific. We therefore question the accuracy of CP case identification 294 
through coding alone. 295 
 296 
It is clear that no one data source provides a comprehensive ascertainment of CP cases. 297 
Inclusion of outpatient data added very little to case ascertainment, as the reason for 298 
attendance was very rarely coded. Approximately half of the CP cases identified in both English 299 
and Welsh inpatient data did not appear with a CP code in the GP data which suggests a 300 
paucity of coding by GPs. Despite the differences in the proportions of data from different 301 
sources available for linkage in each country, the pattern of CP case ascertainment remained 302 
very similar between England and Wales.  303 
 304 
A distinct lack of specificity of codes used across all data sources negates the use of routine 305 
data to investigate healthcare use by type of CP and severity measures are not collected. The 306 
most frequently used code in GP data was “Congenital cerebral palsy”. Similarly, “Cerebral 307 
palsy, unspecified” was most commonly used across secondary care datasets and was 308 
particularly heavily used in the mortality data. This lack of precision is possibly because coding 309 
is applied to records by administrative staff who never see the patients themselves, and thus 310 
rely on the specificity and clarity of the clinicians’ notes to code records. Although coding of the 311 
primary diagnosis is mandatory,35 chronic conditions are often contributory factors to an 312 
admission and may not always be well recorded as a secondary diagnosis.  Coders in the UK 313 
do not receive the same intensity of training as their US counterparts which may also account 314 
for the heavy use of non-specific codes. It has been shown that clinician involvement improves 315 
accuracy of coding36 thus the imminent NHS adoption of SNOMED CT37 (a clinical language to 316 
be used by clinicians in patient electronic records at the point of contact)  has the potential to 317 
improve coding in the future. Further the Community Services Data Set (CSDS)38 that was 318 
introduced from October 2017 should improve the ascertainment of CYP with CP as these 319 
patients are primarily managed by clinicians and therapists within the community setting which 320 
was excluded from routine data collection during the study period. 321 
 322 
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That almost a third of the cases identified were only ever coded for CP once in their records 323 
(despite having multiple NHS contacts) requires further investigation. It is possible that some of 324 
these cases are due to erroneous or abandoned diagnoses. Other explanations could include: 325 
infrequent coding practice, infrequent service use, or cases of CP of lower severity with 326 
associated low morbidity where the condition is not easily apparent or relevant to the clinical 327 
consultation. The age range of the child within the study period and study design may also have 328 
played a part in this high proportion of single coded cases. As it was not possible to follow up 329 
the younger CYP in the study period to the age of 25; patients born later in the study period had 330 
less chance to be identified as they had fewer years of records to search. 331 
 332 
We hypothesized that coding for CP may be inaccurate, and in line with other studies3,32 we 333 
applied a broad selection of codes to include all possible cases of CP (G80-83). It is likely that 334 
false positive cases resulted from including G81.0-G83.3 codes in the definition of cerebral 335 
palsy. However, it is clear from our results that cases of CP (coded G80 or Read equivalent 336 
during at least one NHS contact) can also be coded at another contact with a G81-G83 code. 337 
Hence it is impossible without more complex algorithms to confidently separate true cases of 338 
CP from other conditions with similar physical symptoms using this data alone. Prevalence 339 
estimates for CYP with CP or ‘other paralytic syndromes’ were 3.2 per 1000 for Wales and 3.4 340 
per 1000 for England. However, when excluding cases not explicitly coded as CP, estimated 341 
prevalence was reduced to 2.4 and 2.5 respectively. This figure exceeds the worldwide estimate 342 
of 2.11 per 1000,3 and previous studies of UK prevalence using CP register and survey data 343 
(2.1 in both south east England,39 and in Scotland and selected counties in England).12 344 
However, our lower estimates of prevalence are consistent with that of 2.45 per 1000 previously 345 
published10 for north east England from regional survey data. All the prevalence rates calculated 346 
and reported in this paper are crude rates:  no adjustment has been made for age composition 347 
or any other demographic or socio-economic factors. 348 
 349 
Estimated prevalence rates were higher in males. A finding consistent with previous 350 
publications40-42. Although measures of deprivation used here are relative within each country 351 
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and hence cannot be directly compared between England and Wales, both countries appear to 352 
show a trend towards greater CP prevalence in more deprived areas.  353 
 354 
There are currently many shortcomings inhibiting the use of routine healthcare data to quantify 355 
and analyze healthcare utilization of CYP with a cerebral palsy: validation of coding accuracy is 356 
strongly recommended to underpin the value of future studies using this data as a research 357 
outcome measure. Oskoui et al43 explored the accuracy of identifying known cases of CP from a 358 
regional CP register in a healthcare administrative dataset and identified a sensitivity and 359 
specificity of the administrative claims data of 65.5% and 99.9% respectively suggesting that 360 
administrative data did not capture the full spectrum of CP. The sensitivity was greater for the 361 
more severely affected individuals. We can hypothesize that this may also be the case in our 362 
dataset but without the ability to analyze cases by severity or validate cases against clinical data 363 
or a CP register we cannot be sure. 364 
 365 
Other countries with CP registers may be able to continue this work through the validation of 366 
codes within routine data against CP register data however differences in coding practices 367 
across countries, the quality of routinely-collected data, structure of healthcare services, and 368 
varying levels of coder training make it difficult to generalize results, such as these, across 369 
countries.  370 
 371 
Conclusion 372 
The use of routinely-collected healthcare data within England and Wales for the surveillance of 373 
CYP with CP presents many challenges. These not only lie in the complexities of creating 374 
comprehensive linked datasets but also in the quality of information currently recorded within 375 
those datasets. 376 
 377 
Coding of CP in routine primary and secondary care records data needs radical improvement 378 
within the UK. The introduction of SNOMED CT and the Children and Young People’s Health 379 
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Services Dataset (CYPHS) will hopefully improve case ascertainment in the future, however the 380 
introduction of incentives to code for CP would also be prudent to ensure routine data are coded 381 
both comprehensively and accurately.  382 
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